Abstract

Traditionally, infection with Plasmodium vivax was thought to be benign and self-limiting, however, recent evidence has demonstrated that infection with P. vivax can also result in severe illness and death. Research into P. vivax has been relatively neglected and much remains unknown regarding the biology, pathogenesis and epidemiology of this parasite. One of the fundamental factors governing transmission and immunity is parasite diversity. An understanding of parasite population genetic structure is necessary to understand the epidemiology, diversity, distribution and dynamics of natural P. vivax populations. In addition, studying the population structure of genes under immune selection also enables investigation of the dynamic interplay between transmission and immunity, which is crucial for vaccine development. A lack of knowledge regarding the transmission and spread of P. vivax has been particularly highlighted in areas where malaria control and elimination programmes have made progress in reducing the burden of Plasmodium falciparum, yet P. vivax remains as a substantial obstacle. With malaria elimination back on the global agenda, mapping of global and local P. vivax population structure is essential prior to establishing goals for elimination and the roll-out of interventions. A detailed knowledge of the spatial distribution, transmission and clinical burden of P. vivax is required to act as a benchmark against which control targets can be set and measured. This paper presents an overview of what is known and what is yet to be fully understood regarding P. vivax population genetics, as well as the importance and application of P. vivax population genetics studies.

Highlights

  • Infection with Plasmodium vivax was thought to be benign and self-limiting, recent evidence has demonstrated that infection with P. vivax can result in severe illness and death

  • Mapping of global and local P. vivax population structure is essential prior to establishing goals for elimination and the rollout of interventions, and detailed knowledge of the spatial distribution, transmission and clinical burden of P. vivax is required to act as a benchmark against which control targets can be set and measured [1,19,22,23]

  • The Malaria Eradication Research Agenda Consultative Group on Basic Science and Enabling Technologies recently reported that no campaign for malaria control or elimination can proceed without a comprehensive knowledge of disease epidemiology and host-parasite-vector interactions, and how these interactions are affected by intensified intervention measures [24]

Read more

Summary

Introduction

Infection with Plasmodium vivax was thought to be benign and self-limiting, recent evidence has demonstrated that infection with P. vivax can result in severe illness and death. Genetic diversity of Plasmodium vivax Within a malaria endemic area, multiple parasite clones can often co-infect the same host. Identifying, and distinguishing between clones can be difficult because the genetic diversity of P. vivax populations can vary significantly due to variations in malaria epidemiology in different regions [26,27].

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call